First, although we verified that KIF23 was an adverse prognostic factor in four DLBCL cohorts, the correlations between KIF23 expression and prognosis of patients in different clinical conditions were only analyzed in one GEO dataset (GSE10846 containing 414 samples), since other public datasets lack complete clinical information. The gene discussed is KIF23; the disease is diffuse large B-cell lymphoma.